STOCK TITAN

Insider sale of 5,369 shares at SUPN (NASDAQ: SUPN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SUPN reports a sale of 5,369 shares of Common Stock. The entry lists Morgan Stanley Smith Barney LLC as the broker and describes the shares as restricted stock vesting under a registered plan with a transaction date of 02/22/2025.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for SUPN show?

The Form 144 entry shows a sale of 5,369 common shares. It lists Morgan Stanley Smith Barney LLC as the broker and identifies the shares as restricted stock vesting under a registered plan with date 02/22/2025.

Who is the broker listed on the SUPN Form 144?

The broker is listed as Morgan Stanley Smith Barney LLC. The record gives the broker address as 1 New York Plaza, 8th Floor, New York, NY 10004, tied to the reported sale of 5,369 shares on 02/22/2025.

Are the sold SUPN shares from an award or open‑market purchase?

The shares are described as restricted stock vesting under a registered plan, indicating they arose from a compensation award that vested. The entry ties the vesting/sale event to the 02/22/2025 date in the record.

Does the Form 144 state how proceeds are used?

The excerpt does not provide any use‑of‑proceeds detail. The entry focuses on the security type, 5,369 shares, broker identity, and the 02/22/2025 vesting/sale description without stating proceeds allocation.
Supernus Pharma

NASDAQ:SUPN

View SUPN Stock Overview

SUPN Rankings

SUPN Latest News

SUPN Latest SEC Filings

SUPN Stock Data

2.91B
54.75M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
ROCKVILLE